Corporate insider profile
J. Scott Garland Insider Trades
Latest reported as Director of Enliven Therapeutics, Inc. (ELVN).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$606,719.10
- Latest transaction
- Oct 1, 2026
Affiliated corporations
Reported company relationships
Transaction history
